Legal & General Group’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
85,923
+1,234
| +1% | +$25.9K | ﹤0.01% | 2008 |
|
|
2025
Q1 | $1.39M | Buy |
84,689
+2,247
| +3% | +$36.8K | ﹤0.01% | 2062 |
|
|
2024
Q4 | $2.12M | Buy |
82,442
+12,372
| +18% | +$318K | ﹤0.01% | 1953 |
|
|
2024
Q3 | $2.22M | Buy |
70,070
+1,724
| +3% | +$54.6K | ﹤0.01% | 1922 |
|
|
2024
Q2 | $2.4M | Buy |
68,346
+8,573
| +14% | +$301K | ﹤0.01% | 1856 |
|
|
2024
Q1 | $2.62M | Buy |
59,773
+10,321
| +21% | +$453K | ﹤0.01% | 1808 |
|
|
2023
Q4 | $1.76M | Sell |
49,452
-1,122
| -2% | -$39.9K | ﹤0.01% | 2007 |
|
|
2023
Q3 | $1.36M | Buy |
50,574
+2,415
| +5% | +$65.2K | ﹤0.01% | 2064 |
|
|
2023
Q2 | $1.13M | Buy |
48,159
+32,758
| +213% | +$770K | ﹤0.01% | 2169 |
|
|
2023
Q1 | $211K | Buy |
15,401
+826
| +6% | +$11.3K | ﹤0.01% | 2566 |
|
|
2022
Q4 | $265K | Buy |
14,575
+1,182
| +9% | +$21.5K | ﹤0.01% | 2510 |
|
|
2022
Q3 | $199K | Buy |
13,393
+3,935
| +42% | +$58.5K | ﹤0.01% | 2630 |
|
|
2022
Q2 | $130K | Sell |
9,458
-383
| -4% | -$5.26K | ﹤0.01% | 2779 |
|
|
2022
Q1 | $110K | Buy |
9,841
+62
| +0.6% | +$693 | ﹤0.01% | 2842 |
|
|
2021
Q4 | $231K | Buy |
9,779
+6,462
| +195% | +$153K | ﹤0.01% | 2671 |
|
|
2021
Q3 | $84K | Buy |
3,317
+375
| +13% | +$9.5K | ﹤0.01% | 2882 |
|
|
2021
Q2 | $62K | Buy |
2,942
+1,333
| +83% | +$28.1K | ﹤0.01% | 2886 |
|
|
2021
Q1 | $38K | Buy |
1,609
+168
| +12% | +$3.97K | ﹤0.01% | 2910 |
|
|
2020
Q4 | $20K | Hold |
1,441
| – | – | ﹤0.01% | 3090 |
|
|
2020
Q3 | $18K | Sell |
1,441
-173
| -11% | -$2.16K | ﹤0.01% | 3003 |
|
|
2020
Q2 | $23K | Buy |
+1,614
| New | +$23K | ﹤0.01% | 3006 |
|